Literature DB >> 10889823

Histopathological changes associated with high intensity focused ultrasound (HIFU) treatment for localised adenocarcinoma of the prostate.

G J Van Leenders1, H P Beerlage, E T Ruijter, J J de la Rosette, C A van de Kaa.   

Abstract

AIMS: Investigation of the histopathological changes in prostatectomy specimens of patients with prostate cancer after high intensity focused ultrasound (HIFU) and identification of immunohistochemical markers for tissue damage after HIFU treatment.
METHODS: Nine patients diagnosed with adenocarcinoma of the prostate underwent unilateral HIFU treatment seven to 12 days before radical prostatectomy. The prostatectomy specimens were analysed histologically. Immunohistochemical staining and electron microscopy were performed to characterise more subtle phenotypic changes.
RESULTS: All prostatectomy specimens revealed well circumscribed HIFU lesions at the dorsal side of the prostate lobe treated. Most epithelial glands in the centre of the HIFU lesions revealed signs of necrosis. Glands without apparently necrotic features were also situated in the HIFU lesions, raising the question of whether lethal destruction had occurred. This epithelium reacted with antibodies to pancytokeratin, prostate specific antigen (PSA), and Ki67, but did not express cytokeratin 8, which is indicative of severe cellular damage. Ultrastructural examination revealed disintegration of cellular membranes and cytoplasmic organelles consistent with cell necrosis. HIFU treatment was incomplete at the ventral, lateral, and dorsal sides of the prostate lobe treated.
CONCLUSIONS: HIFU treatment induces a spectrum of morphological changes ranging from apparent light microscopic necrosis to more subtle ultrastructural cell damage. All HIFU lesions are marked by loss of cytokeratin 8. HIFU does not affect the whole area treated, leaving vital tissue at the ventral, lateral, and dorsal sides of the prostate.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10889823      PMCID: PMC1731195          DOI: 10.1136/jcp.53.5.391

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  16 in total

1.  Local control of prostate cancer by transrectal high intensity focused ultrasound therapy: preliminary results.

Authors:  A Gelet; J Y Chapelon; R Bouvier; C Pangaud; Y Lasne
Journal:  J Urol       Date:  1999-01       Impact factor: 7.450

2.  The urodynamic impact of transrectal high-intensity focused ultrasound on bladder outflow obstruction.

Authors:  S Madersbacher; C H Klingler; G Schatzl; C P Schmidbauer; M Marberger
Journal:  Eur Urol       Date:  1996       Impact factor: 20.096

Review 3.  Cryosurgical ablation for prostate cancer: a current review.

Authors:  C D Zippe
Journal:  Semin Urol       Date:  1995-05

4.  Early experience with high-intensity focused ultrasound for the treatment of benign prostatic hypertrophy.

Authors:  L D Sullivan; M G McLoughlin; L G Goldenberg; M E Gleave; K W Marich
Journal:  Br J Urol       Date:  1997-02

5.  The efficacy and complications of salvage cryotherapy of the prostate.

Authors:  L L Pisters; A C von Eschenbach; S M Scott; D A Swanson; C P Dinney; C A Pettaway; R J Babaian
Journal:  J Urol       Date:  1997-03       Impact factor: 7.450

6.  Effect of high-intensity focused ultrasound on human prostate cancer in vivo.

Authors:  S Madersbacher; M Pedevilla; L Vingers; M Susani; M Marberger
Journal:  Cancer Res       Date:  1995-08-01       Impact factor: 12.701

7.  Treatment of prostate cancer with transrectal focused ultrasound: early clinical experience.

Authors:  A Gelet; J Y Chapelon; R Bouvier; R Souchon; C Pangaud; A F Abdelrahim; D Cathignol; J M Dubernard
Journal:  Eur Urol       Date:  1996       Impact factor: 20.096

8.  High-intensity focused ultrasound (HIFU) in the treatment of benign prostatic hyperplasia (BPH).

Authors:  T Ebert; M Graefen; S Miller; D Saddeler; B Schmitz-Dräger; R Ackermann
Journal:  Keio J Med       Date:  1995-12

9.  [High-dose-rate brachytherapy of prostatic carcinoma with iridium 192].

Authors:  J U Schwarzer; R Hofmann; P Kneschaurek; P Lukas; A Lindner; J Braun
Journal:  Strahlenther Onkol       Date:  1992-01       Impact factor: 3.621

10.  Morbidity of pelvic lymphadenectomy, radical retropubic prostatectomy and external radiotherapy in patients with localised prostatic cancer.

Authors:  O Bratt; P Elfving; P Flodgren; R Lundgren
Journal:  Scand J Urol Nephrol       Date:  1994-09
View more
  23 in total

1.  Coagulation and ablation patterns of high-intensity focused ultrasound on a tissue-mimicking phantom and cadaveric skin.

Authors:  Hee-Jin Kim; Han Gu Kim; Zhenlong Zheng; Hyoun Jun Park; Jeung Hyun Yoon; Wook Oh; Cheol Woo Lee; Sung Bin Cho
Journal:  Lasers Med Sci       Date:  2015-09-04       Impact factor: 3.161

Review 2.  A review of low-intensity ultrasound for cancer therapy.

Authors:  Andrew K W Wood; Chandra M Sehgal
Journal:  Ultrasound Med Biol       Date:  2015-04       Impact factor: 2.998

3.  Cavernosal nerve functionality evaluation after magnetic resonance imaging-guided transurethral ultrasound treatment of the prostate.

Authors:  Steffen Sammet; Ari Partanen; Ambereen Yousuf; Christina L Sammet; Emily V Ward; Craig Wardrip; Marek Niekrasz; Tatjana Antic; Aria Razmaria; Keyvan Farahani; Shunmugavelu Sokka; Gregory Karczmar; Aytekin Oto
Journal:  World J Radiol       Date:  2015-12-28

4.  Antivascular ultrasound therapy extends survival of mice with implanted melanomas.

Authors:  Andrew K W Wood; Susan M Schultz; William M-F Lee; Ralph M Bunte; Chandra M Sehgal
Journal:  Ultrasound Med Biol       Date:  2010-04-09       Impact factor: 2.998

5.  Assessment of histopathological features of needle biopsy in recurrent prostate cancer following salvage high-intensity focused ultrasound.

Authors:  Michele Billia; Khurram M Siddiqui; Susanne Chan; Fan Li; Ali Al-Zahrani; Jose A Gomez; Joseph L Chin
Journal:  Can Urol Assoc J       Date:  2016 Nov-Dec       Impact factor: 1.862

6.  High intensity focused ultrasound-induced gene activation in sublethally injured tumor cells in vitro.

Authors:  Yunbo Liu; Takashi Kon; Chuanyuan Li; Pei Zhong
Journal:  J Acoust Soc Am       Date:  2005-11       Impact factor: 1.840

Review 7.  Harnessing the immunomodulatory effect of thermal and non-thermal ablative therapies for cancer treatment.

Authors:  Christopher Bastianpillai; Neophytos Petrides; Taimur Shah; Stephanie Guillaumier; Hashim U Ahmed; Manit Arya
Journal:  Tumour Biol       Date:  2015-09-30

8.  Comparison of continuous vs. pulsed focused ultrasound in treated muscle tissue as evaluated by magnetic resonance imaging, histological analysis, and microarray analysis.

Authors:  Walter Hundt; Esther L Yuh; Silke Steinbach; Mark D Bednarski; Samira Guccione
Journal:  Eur Radiol       Date:  2008-01-19       Impact factor: 5.315

9.  Microbubbles assist goat liver ablation by high intensity focused ultrasound.

Authors:  Tinghe Yu; Xionglin Fan; Shuhua Xiong; Kai Hu; Zhibiao Wang
Journal:  Eur Radiol       Date:  2006-03-16       Impact factor: 5.315

10.  Boosting high-intensity focused ultrasound-induced anti-tumor immunity using a sparse-scan strategy that can more effectively promote dendritic cell maturation.

Authors:  Fang Liu; Zhenlin Hu; Lei Qiu; Chun Hui; Chao Li; Pei Zhong; Junping Zhang
Journal:  J Transl Med       Date:  2010-01-27       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.